EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches

Mina Iskandar iD, Miguel Xiao Barbero iD, Muhamed Jaber, Roy Chen iD, Romulo Gomez-Guevara, Edwin Cruz, Sandy Westerheide

Cancers · 14.01.2025 · 17 (2) · 257

DOI: 10.3390/cancers17020257 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.01.2025. Verfasst von Mina Iskandar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences, University of South Florida, 4202 East Fowler Avenue, ISA2015, Tampa, FL 33620, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 541 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: As cells divide, telomeres shorten through a phenomenon known as telomere attrition, which leads to unavoidable senescence of cells. Unprotected DNA exponentially increases the odds of mutations, which can evolve into premature aging disorders and tumorigenesis. There has been growing academic and clinical interest in exploring this duality and developing optimal therapeutic strategies to combat telomere attrition in aging and cellular immortality in cancer. The purpose of this review is to provide an updated overview of telomere biology and therapeutic tactics to address aging and cancer.

Methods

We used the Rayyan platform to review the PubMed database and examined the ClinicalTrial.gov registry to gain insight into clinical trials and their results.

Results

Cancer cells activate telomerase or utilize alternative lengthening of telomeres to escape telomere shortening, leading to near immortality. Contrarily, normal cells experience telomeric erosion, contributing to premature aging disorders, such as Werner syndrome and Hutchinson–Gilford Progeria, and (2) aging-related diseases, such as neurodegenerative and cardiovascular diseases.

Conclusions

The literature presents several promising therapeutic approaches to potentially balance telomere maintenance in aging and shortening in cancer. This review highlights gaps in knowledge and points to the potential of these optimal interventions in preclinical and clinical studies to inform future research in cancer and aging.

Schlagwörter

Stichwörter der Autor:innen

age-related diseasesagingalternative lengthening of telomerebiomarkerscancerpremature aging disorderstelomerase reactivationtelomere attritiontherapeutics

Autor:innen und Institutionen

  • Department of Molecular Biosciences, University of South Florida, 4202 East Fowler Avenue, ISA2015, Tampa, FL 33620, USA.

ORCID-Profile: Mina Iskandar, Miguel Xiao Barbero, Roy Chen

Zitieren

APA

Iskandar, M., Xiao Barbero, M., Jaber, M., Chen, R., Gomez-Guevara, R., Cruz, E., & Westerheide, S. (2025). A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches. Cancers, 17(2), 257. https://doi.org/10.3390/cancers17020257

Vancouver

Iskandar M, Xiao Barbero M, Jaber M, Chen R, Gomez-Guevara R, Cruz E, et al. A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches. Cancers. 2025;17(2):257. doi:10.3390/cancers17020257

BibTeX
@article{Iskandar2025,
  author = {Iskandar, Mina and Xiao Barbero, Miguel and Jaber, Muhamed and Chen, Roy and Gomez-Guevara, Romulo and Cruz, Edwin and Westerheide, Sandy},
  title = {A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {257},
  doi = {10.3390/cancers17020257}
}
Kostenlos starten →